STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
批准号:
7602011
负责人:
WAYNE I LENCER
金额:
$6.46万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-03 至 2008-05-31
关键词:
AffectBindingBiologicalBiological ProcessBiologyCell LineCellsCeramidesComplexComputer Retrieval of Information on Scientific Projects DatabaseCouplingDetectionEndocytosisEpithelial CellsFundingGD1a gangliosideGangliosidesGlycosphingolipidsGrantHumanHydroxylationInstitutionIntestinesKidneyLengthMembrane MicrodomainsMethodsMonkeysOligosaccharidesPolysaccharidesResearchResearch PersonnelResolutionResourcesRoleSamplingSolutionsSourceSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStandards of Weights and MeasuresStructureSurfaceToxinUnited States National Institutes of HealthVariantVero Cellscholeragen receptorganglioside receptorpreventresearch studysinapinic acidtrafficking
中文摘要
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
鞘糖脂和神经节苷脂参与多种生物过程,其生物学作用取决于寡糖和神经酰胺部分的结构。在这里,振动冷却(VC)MALDI-FTMS用于检测不稳定的物种,然后通过SORI-CAD和IRMPD进行有效的片段化。GM 1和GD 1a神经节苷脂分别作为霍乱毒素和相关LTIIb毒素的运输受体。我们假设GD 1a神经节苷脂的人肠细胞是不相关的脂筏,由于其神经酰胺结构的变化,这阻止了LTIIb-GD 1a复合物的内吞作用。毒素受体 评价神经节苷脂结构作为该功能的调节剂,包括神经酰胺链长度、饱和和羟基化水平以及聚糖组成。为了分析这些分子,使用我们先前开发的TLC板与VC-MALDI-FTMS直接偶联的方法。这允许直接TLC-MALDI-FTMS,而不会因TLC板的表面不规则性而对FT高分辨率和质量准确度产生不利影响。碰撞冷却对于稳定和检测完整的神经节苷脂是必要的。将鞘糖脂标准品溶于CHCl 3/MeOH中,并以芥子酸作为基质施加到MALDI靶标上。以前的实验已经描述了从极化肠上皮细胞系T-84和猴肾Vero细胞中纯化神经节苷脂以及对毒素生物学机制的功能研究。我们已经描述了VC MALDI-FTMS的神经节苷脂分离和仪器参数。在当前研究中,将整个HP-TLC板或从含有样品轨道的板上切下的条带连接到MALDI样品探针上,并将饱和基质溶液喷洒在顶部。将样品以~ 0.2mm的取样步长直接从TLC板表面MALDI解吸。随后通过SORI-CAD和IRMPD进行片段化。观察到唾液酸化和高度岩藻糖基化的鞘糖脂。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Glycosphingolipids and gangliosides participate in diverse biological processes, and their biological roles are dependent on the structures of both the oligosaccharide and the ceramide portions. Here, vibrationally cooled (VC)MALDI-FTMS was used for the detection of labile species followed by their efficient fragmentation by SORI-CAD and IRMPD. GM1 and GD1a gangliosides serve as trafficking receptors for cholera toxin and the related LTIIb toxin, respectively. We assume that GD1a ganglioside of human intestinal cells is not associated with lipid rafts due to its ceramide structural variation, which prevents endocytosis of the LTIIb-GD1a complex. The toxin receptors ganglioside structures were evaluated as a moderator of this function, including ceramide chain length, level of saturation and hydroxylation, as well as glycan composition. To analyze these molecules, our previously developed method of direct coupling of TLC plates with VC-MALDI-FTMS was used. This allows direct TLC-MALDI-FTMS without adversely affecting the FT high resolution and mass accuracy by the surface irregularity of the TLC plate. Collisional cooling is necessary for stabilization and detection of intact gangliosides. Glycosphingolipids standards were dissolved in CHCl3/MeOH and applied onto the MALDI target with sinapinic acid as a matrix. Previous experiments have described ganglioside purification from polarized intestinal epithelial cell line T-84 and monkey kidney Vero cells and functional studies on the mechanism of toxin biology. We have described ganglioside separations and instrumental parameters for VC MALDI-FTMS. In the current study, the whole HP-TLC plate or the strip cut from plate containing the sample track was attached to the MALDI sample probe, and saturated matrix solution was sprayed on top. The samples were MALDI-desorbed directly off TLC plate surfaces with ~0.2 mm sampling steps. Fragmentation was subsequently performed by SORI-CAD and IRMPD. Both sialylated and highly fucosylated glycosphingolipids were observed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
-
批准号:10214604
-
项目类别:
-
资助金额:$51.69万
-
财政年份:2020
-
负责人:WAYNE I LENCER
-
依托单位:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
-
批准号:10626015
-
项目类别:
-
资助金额:$49.24万
-
财政年份:2020
-
负责人:WAYNE I LENCER
-
依托单位:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
-
批准号:10405643
-
项目类别:
-
资助金额:$49.24万
-
财政年份:2020
-
负责人:WAYNE I LENCER
-
依托单位:
Intestinal Disease-enterocyte toxin interaction
-
批准号:9263933
-
项目类别:
-
资助金额:$71.69万
-
财政年份:2016
-
负责人:WAYNE I LENCER
-
依托单位:
Intestinal Disease-enterocyte toxin interaction
-
批准号:9167689
-
项目类别:
-
资助金额:$74.19万
-
财政年份:2016
-
负责人:WAYNE I LENCER
-
依托单位:
Intestinal Disease-enterocyte toxin interaction
-
批准号:9899224
-
项目类别:
-
资助金额:$71.69万
-
财政年份:2016
-
负责人:WAYNE I LENCER
-
依托单位:
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
-
批准号:8365529
-
项目类别:
-
资助金额:$0.38万
-
财政年份:2011
-
负责人:WAYNE I LENCER
-
依托单位:
Unsaturated glycoceramide as novel platform for mucosal vaccine and drug delivery
-
批准号:8145606
-
项目类别:
-
资助金额:$21.51万
-
财政年份:2010
-
负责人:WAYNE I LENCER
-
依托单位:
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
-
批准号:8170895
-
项目类别:
-
资助金额:$0.46万
-
财政年份:2010
-
负责人:WAYNE I LENCER
-
依托单位:
Unsaturated glycoceramide as novel platform for mucosal vaccine and drug delivery
-
批准号:8030610
-
项目类别:
-
资助金额:$25.79万
-
财政年份:2010
-
负责人:WAYNE I LENCER
-
依托单位:
FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells
-
批准号:8538945
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells
-
批准号:7903438
-
项目类别:
-
资助金额:$40.85万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
FASEB Summer Research Conference 2009
-
批准号:7614152
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells
-
批准号:8133845
-
项目类别:
-
资助金额:$37.06万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells
-
批准号:7713651
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
-
批准号:7955924
-
项目类别:
-
资助金额:$0.47万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells
-
批准号:8322163
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
-
批准号:7723017
-
项目类别:
-
资助金额:$3.89万
-
财政年份:2008
-
负责人:WAYNE I LENCER
-
依托单位:
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
-
批准号:7369281
-
项目类别:
-
资助金额:$4.52万
-
财政年份:2006
-
负责人:WAYNE I LENCER
-
依托单位:
Administrative Core
-
批准号:7499778
-
项目类别:
-
资助金额:$71.11万
-
财政年份:2006
-
负责人:WAYNE I LENCER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: